AXP

Warren Buffett’s conglomerate bought $16 billion of stocks and sold $24 billion in the first quarter, a regulatory filing reveals.

Berkshire Hathaway bought a sizable stake in Delta Air Lines in Greg Abel’s first quarter at the helm since succeeding Warren Buffett, returning to a stock the conglomerate previously invested in several years ago. Abel took over as CEO in January. In his first letter to shareholders in February, Abel made clear there are positions he considers “core,” such as Apple, American Express, Coca-Cola and Moody’s, and wrote that Berkshire would continue its “concentrated approach” to stock investing.

Klarna Group plc KLAR reported first-quarter 2026 loss per share of a penny, a 96.2% improvement from the year-ago loss of 26 cents. The bottom line beat the Zacks Consensus Estimate of a loss of 18 cents. Quarterly revenues jumped 44.4% year over year to $1.01 billion and topped the consensus mark by 7.6%. The quarter was supported by higher transactions, GMV, reflecting higher consumer engagement, a widening merchant network and increased interest income. Klarna Group plc price-consensus-eps-surprise-chart | Klarna Group plc Quote Klarna continued to expand both sides of its payments network in the quarter. Active consumers climbed 21% year over year to 119 million, while merchants rose 49% to 1.075 million, underscoring broadening distribution and adoption. Under the hood, GMV growth remained balanced geographically, with U.S. GMV rising 39% to $7.1 billion and global GMV outside the United States increasing 31% to $26.6 billion. Product mix also kept shifting, with point-of-sale installments (Fair Financing) GMV rising 138% year over year and representing 12% of total GMV. Total GMV of $33.7 billion beat the Zacks Consensus Estimate by 4.5%. Transaction and service revenues increased 29% year over year to $671 million (beating the consensus estimate by 4.2%), while interest income advanced 56% to $284 million (beating the consensus estimate by 18.8%. On a geographic basis, revenues in the United States rose to $399 million from $238 million a year ago, while Germany delivered $221 million and the U.K. contributed $111 million. Transaction margin dollars (TMD) reached $389 million in the quarter, up 44% year over year. That growth tracked revenue expansion and reflected improving unit economics as the loan book matures. Costs tied to transactions climbed alongside volume and product mix. Processing and servicing costs increased 62% year over year to $266 million, while funding costs rose 32% to $171 million. Provision for credit losses totaled $186 million, and the provision rate was 0.55% of GMV, supported by seasonally stronger credit performance and continued maturation of the Fair Financing portfolio. Net income reached $1 million, improving from a net loss of $99 million a year ago, translating to a 0.1% net income margin. Klarna ended the quarter with $2.8 billion in cash and cash equivalents, which declined from $3.8 billion at 2025-end. Total asse...

i-80 Gold (AMEX:IAUX) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. View the webcast at https://app.webinar.net/YWEQaPqn3wA I-80 Gold Corp reported a strong start to 2026, highlighting the completion of a $1 billion recapitalization that secures funding for phase one and two of their development strategy, including refurbishing the Lone Tree processing facility and developing new projects. Record quarterly revenue and gross profit were achieved, driven by increased gold production and sales, despite a few operational setbacks like the transformer failure at Granite Creek. The company initiated its largest drilling program to date to support upcoming feasibility and pre-feasibility studies, aiming to significantly increase gold production by 2028 and complete multiple key projects within the next few years. OPERATOR Hello and thank you for joining I-80 Gold Corp's 2026 First Quarter Results Conference call and webcast. Today's company presenters include Richard Young, President and Chief Executive Officer of I-80 Gold Corp, Paul Charun, COO and Ryan Snow, CFO. Before we continue, please note that today's comments may contain forward looking statements which involve risks and uncertainties. Actual results could differ materially. I ask everyone to refer to slide 2 of the presentation which is available on I-80 Gold Corp's website to view the cautionary notes regarding the forward looking statements made on this call and the risk factors related to these statements. All amounts are in US Dollars unless otherwise stated. Following today's format presentation, we will open the call to your questions. I'll now hand the call over to Richard. Richard Young (President and Chief Executive Officer) Well thank you Vincent and hello and thank you for joining today's call. Starting with slide three, we're off to a strong start in 2026 advancing our growth strategy to create a Nevada based mid tier gold producer. We are pleased to now have the recapitalization behind us as we completed the recapitalization in the first quarter, a task that took about 12 months to complete. Through a series of financing transactions we've secured over $1 billion providing funding c...

Birchtech (AMEX:BCHT) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. View the webcast at https://viavid.webcasts.com/starthere.jsp?ei=1761146&tp_key=1b46e148b3 Birchtech Corp completed a $16.4 million capital raise and uplisted to the NYSE American, strengthening its balance sheet and expanding its investor base. First quarter 2026 revenues increased by 32% to $4.2 million, driven by growth in the air and water segments; gross profit rose to $1.4 million with a 33% gross margin. The company is actively pursuing enforcement of a $78 million patent infringement judgment and anticipates converting legal settlements into long-term commercial partnerships. Strategic initiatives include expanding recurring activated carbon sales, scaling the water business, and launching the SEA IX ion exchange product line targeting a $220 million market. Management emphasized the transition from enforcement targets to commercial partnerships, expecting activated carbon sales to significantly grow and contribute to revenue. The company reported a net loss of $1.3 million for Q1 2026 but highlighted a strong cash position of $14.7 million post-capital raise, with no debt. Future plans include converting more licensed utilities into recurring product supply customers and advancing agreements for their carbon rejuvenation facility. OPERATOR Good afternoon ladies and gentlemen. Thank you for standing by. Welcome to Birch Tech's first quarter 2026 earnings conference call. During today's presentation, all parties will be in a listen only mode. Following the presentation, the conference will be open for questions for dial in participants this conference is being recorded today, Wednesday, May 13, 2026 and the earnings press release accompanying this conference call was issued after the market closed today. On our call today is BirchTech's President and CEO Richard McPherson and CFO Michael Myoska. Before we get started, I'll read a disclaimer about Forward looking Statements. This conference call may contain, in addition to historical information, forward looking statements that are made pursuant to the safe harbor provisions of the U.S. private Securities Litigati...

Xtant Medical Hldgs (AMEX:XTNT) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full earnings call is available at https://www.webcaster5.com/Webcast/Page/3039/53872 Xtant Medical Holdings Inc reported first quarter 2026 revenue of $20.9 million, a decrease from the previous year, but raised full-year revenue guidance to $101 million to $105 million. The company entered a transformational license agreement with Dillon Technologies for the HemoBlast Bellows product, expanding its portfolio into a $2 billion hemostatic agent market. The Companion Spine transaction was finalized, providing $10.7 million in proceeds to reduce debt and refocus on high-margin biologics, leading to a strengthened balance sheet. Operational highlights include the commercial launch of Trivium Shaped, enhancing the company's product offerings in the orthopedic sector. Management emphasized strategic growth in biologics and plans to expand the sales force to leverage new product introductions. OPERATOR Good morning everyone and thank you and welcome to the Xtant Medical first quarter 2026 financial results. At this time, all participants are in a listen only mode. The floor will be open for questions and comments following the presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Kevin Gardner of LifeSci Advisors. Kevin Gardner (Moderator) Thank you operator and welcome to Xtant Medical's first quarter 2026 financial results call. Joining me today are Sean Brown, President and Chief Executive Officer and Scott Neals, Chief Financial Officer. Today's call is being webcast and will be posted on the Company's website for playback. During the course of this call, management may make certain forward looking statements regarding future events and the Company's expected future performance. These forward looking statements reflect Xtant's current perspective on existing trends and information and can be identified by such words as expect, plan, will, may, anticipate, believe, should, intends and other words with similar meaning. Such forward looking statements are not guarantees of future performance and involve risks and unce...

On Wednesday, Tecogen (AMEX:TGEN) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. The full earnings call is available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=8pPLOnGc Tecogen reported a gross profit margin improvement to over 40% in Q1 2026, despite higher operating expenses due to investments in R&D and marketing. The company anticipates substantial customer deposits from closed projects to enhance its cash position, currently at approximately $8.5 million. Tecogen highlighted a strategic partnership with Vertiv, including a significant purchase order for chillers expected imminently, showcasing a strong commitment to the data center market. The company experienced a decrease in total revenues by 12.9% to $6.4 million compared to the previous year, primarily due to reduced product revenues. Operating expenses increased due to manufacturing expansion and R&D, but cost reduction initiatives are expected to decrease OPEX starting in Q2 2026. Tecogen is hosting several prospective data center customers for product demonstrations to convert interest into purchase orders, indicating strong potential for future sales growth. Despite a net loss of $2.2 million, Tecogen is optimistic about its data center market opportunities and has a robust pipeline for both data center and non-data center projects. OPERATOR Welcome to the Tecogen Q1 2026 conference call. this time all participants are in a listen only mode. A question and answer session will follow the formal presentation. It is now my pleasure to introduce your host, Jack Whiting, General Counsel and Secretary. Thank you. You may begin. Jack Whiting (General Counsel and Secretary) Good morning, this is Jack Whiting, General Counsel and Secretary, Tekogen. This call is being recorded and will be archived on our [email protected] the press release regarding our first quarter 2026 earnings and the presentation provided this morning are available in the Investor section of our website. I direct your attention to our safe harbor statement included in our earnings press release and presentation. Various remarks that we may make about the company's expectation, plans and prospects constitute forward lookin...

Palatin Techs (AMEX:PTN) held its third-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. Access the full call at https://www.webcaster5.com/Webcast/Page/2953/54002 Palatin Techs reported $3.9 million in collaboration and license revenue for Q3 2026, marking an increase from no revenue in the prior year, primarily due to the Altanisbac agreement. The company recorded a net loss of $1.4 million, significantly improved from a $4.8 million net loss in the previous year, driven by increased revenue. Palatin Techs is advancing its melanocortin 4 receptor therapies for rare obesity disorders, focusing on improving tolerability and usability, with plans to submit an IND for their peptide program in Q4 2026. The company has strategic partnerships, including with Bergel Ingelheim and Altanisbac Labs, providing non-dilutive capital and future royalty opportunities. Management is confident in developing best-in-class therapies, highlighting improvements in selectivity and potency, especially in their oral small molecule program. OPERATOR Hello everyone. Welcome to Palatin's third quarter fiscal year 2026 operating results conference call. At this time, all participants are on a listen only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference call is being recorded. Before we begin our remarks, I would like to remind you that the statements made by Palatin are not historical facts and may be forward looking statements. These statements are based on assumptions that may or may not prove to be accurate and that the actual results may differ materially from those anticipated and due to the variety of risks and uncertainties discussed in the Company's recent filings with the Securities and Exchange Commission. Please consider such risks and uncertainties carefully in evaluating these forward looking statements by Palatin's prospects. Now I would like to turn the call over to your host, Dr. Carl Spana, President and Chief Executive Officer of Palatin. Please go ahead. Thank you. Dr. Carl Spana (President and Chief Executive Officer) Goo...

Westwater Resources (AMEX:WWR) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. The full earnings call is available at https://events.q4inc.com/attendee/265765325 Westwater Resources Inc reported a net loss of approximately $4.7 million for the quarter, an increase from the previous year's $2.7 million, attributed to increased permitting costs and product development at Kellyton. The company is advancing its vertically integrated graphite platform in Alabama, focusing on the Kooza graphite deposit and the Kellyton graphite plant, and has invested $29.6 million in the project to date. Westwater Resources Inc is actively seeking non-dilutive financing options, including government funding, to complete the $245 million Phase 1 capital estimate for Kellyton, with $41.5 million of cash on hand and additional undrawn capital available. The company received FAST41 designation for CUSA, which improves federal permitting coordination, and expects the permitting process to take 12-24 months. Despite the termination of a procurement agreement with SKL, the company continues to engage with prospective customers across various sectors and remains optimistic about domestic demand for battery-grade graphite. OPERATOR Hello everyone. Thank you for joining us and welcome to Westwater Resources Inc Q1 2026 conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Steve Cates. CFO Steve, please go ahead. Steve Cates (Chief Financial Officer) Thank you Operator and good morning everyone. Thank you for joining us today for Westwater Resources first quarter 2026 business update. Our Form 10Q was filed and issued yesterday after market close and is available in the Investors section of our website at westwaterresources.com joining me on the call today are Terence Krein, our Executive Chairman, and Frank Bakker, our President and Chief Executive Officer. Both will be available to answer questions following our prepared remarks. As a re...

Buda Juice (AMEX:BUDA) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. The full earnings call is available at https://events.q4inc.com/attendee/605302226 Buda Juice reported a 17.7% year-over-year revenue growth for the first quarter of 2026, driven entirely by its existing customer base. The company faced a temporary gross margin decline due to a spike in lime costs caused by supply chain disruptions in Mexico, but expects recovery in the second quarter. Buda Juice announced a major expansion into 256 Walmart stores across nine states, significantly increasing its store count by more than 75%. Operational efficiencies were highlighted with labor costs as a percentage of revenue improving by over 150 basis points year-over-year. Despite increased general and administrative expenses due to public company costs, the company remains profitable and debt-free, ending the quarter with $20 million in cash. Management emphasized continued strategic focus on expanding distribution and maintaining profitability while diversifying its geographic footprint beyond Texas. Dennis (Operator) Hello and thank you for standing by. My name is Dennis and I will be your conference operator today. At this time I would like to welcome everyone to the Buda Juice first quarter 2026 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press STAR followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. I would now like to turn the call over to Brian Siegel, Investor Relations. Please go ahead. Brian Siegel (Investor Relations) Thank you Dennis. During today's call, Horatio Lanzdel Hands, Buda Juice's Chief Executive Officer and Clint Bowers, Buda Juice's Chief Financial Officer, will discuss Buda Juice's financial and operational results that were reported this morning. Any forward looking statements made during this conference call, during the prepared remarks or in the question and answer session, whether general or specific in nature, are su...

• Similarweb (NYSE:SMWB) is estimated to report quarterly earnings at $0.01 per share on revenue of $72.97 million. • Dominari Holdings (NASDAQ:DOMH) is projected to report earnings for its first quarter. • CTW Cayman (NASDAQ:CTW) is projected to report earnings for its first quarter. • Milestone Pharmaceuticals (NASDAQ:MIST) is projected to report quarterly earnings at $0.14 per share on revenue of $45.13 million. • Paysafe (NYSE:PSFE) is expected to report quarterly earnings at $0.35 per share on revenue of $424.33 million. • Caesarstone (NASDAQ:CSTE) is projected to report quarterly loss at $0.35 per share on revenue of $97.80 million. • Buda Juice (AMEX:BUDA) is expected to report quarterly earnings at $0.03 per share on revenue of $3.20 million. • Kamada (NASDAQ:KMDA) is expected to report quarterly earnings at $0.12 per share on revenue of $124.20 million. • Kornit Digital (NASDAQ:KRNT) is likely to report quarterly loss at $0.04 per share on revenue of $46.67 million. • Beasley Broadcast Group (NASDAQ:BBGI) is estimated to report earnings for its first quarter. • Xtant Medical Holdings (AMEX:XTNT) is expected to report quarterly loss at $0.02 per share on revenue of $19.79 million. • PDS Biotechnology (NASDAQ:PDSB) is projected to report earnings for its first quarter. • Humacyte (NASDAQ:HUMA) is likely to report quarterly loss at $0.11 per share on revenue of $1.42 million. • Hyatt Hotels (NYSE:H) is likely to report quarterly earnings at $0.63 per share on revenue of $2.33 billion. • Protalix BioTherapeutics (AMEX:PLX) is likely to report quarterly loss at $0.01 per share on revenue of $11.47 million. • Eos Energy Enterprises (NASDAQ:EOSE) is likely to report quarterly loss at $0.24 per share on revenue of $56.41 million. • Riskified (NYSE:RSKD) is likely to report quarterly earnings at $0.02 per share on revenue of $87.64 million. • Aprea Therapeutics (NASDAQ:APRE) is estimated to report earnings for its first quarter. • Immunic (NASDAQ:IMUX) is estimated to report earnings for its first quarter. • Valens Semiconductor (NYSE:VLN) is likely to report quarterly loss at $0.07 per share on revenue of $16.47 million. • DarioHealth (NASDAQ:DRIO) is projected to report quarterly loss at $0.90 per share on revenue of $5.48 million. • Compass Pathways (NASDAQ:CMPS) is likely to report earnings for its first quarter. • Zenas BioPharma (NASDAQ:ZBIO) is expect...

Financial services technology solutions provider Fidelity National Information Services, Inc. FIS is set to report first-quarter 2026 results on May 8, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $1.28 per share,and the same for revenues is pinned at $3.27 billion. The first-quarter earnings estimate witnessed two downward revisions against no movement in the opposite direction over the past 60 days. However, the bottom-line prediction indicates a 5.8% year-over-year increase. The Zacks Consensus Estimate for quarterly revenues implies year-over-year growth of 29.3%. Image Source: Zacks Investment Research For full-year 2026, the Zacks Consensus Estimate for Fidelity National’s revenues is pegged at $13.75 billion, implying a rise of 28.8% year over year. Meanwhile, the consensus mark for the current year EPS is pegged at $6.27, implying growth of around 9% on a year-over-year basis. Fidelity National’s earningsbeat the consensus estimate in two of the last four quarters, met once and missed on another occasion, with the average surprise being 0.6%. Fidelity National Information Services, Inc. price-eps-surprise | Fidelity National Information Services, Inc. Quote Our proven model predicts a likely earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is precisely the case here. FIS has an Earnings ESP of +0.17% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Banking Solutions revenues indicates a 37.7% year-over-year increase. The acquisition of Global Payments’ Issuer Solutions business, which was closed in January, is likely to boost the performance of the segment. The consensus mark indicates a 7.2% increase in revenues from Capital Market Solutions compared with the same quarter last year. The Zacks Consensus Estimate for Banking Solutions’ adjusted EBITDA indicates a 42% year-over-year increase. The consensus mark for Capital Market Solutions’ adjusted EBITDA indicates 11.9% year-over-year growth. The factors stated above are likely to have positioned FIS for year-ove...